MM&M Awards: tonight's the night

Share this article:
With the 2008 MM&M Awards just hours away, the excitement is building.

Upwards of 750 top healthcare marketing and communications execs will don black ties, tuxes, capes and cocktail dresses for the industry's most glamorous and meaningful awards this evening. They'll converge on Tavern on the Green in Central Park, where they'll sip cocktails and mingle with colleagues and competitors before taking their seats for the night's festivities—a sumptuous meal, a double-helping of suspense and a celebration of the best marketing in the business. Then they'll retire to the bar for the Afterglow party, some clutching Awards, others a drink and the promise of a shot at the gold next time around.  
 
Emceed by comedian Elon Gold, the MM&M Awards 2008 ceremony will recognize exceptional creativity and marketing effectiveness in healthcare across multiple channels. This year we received a record number of 830 entries. Only 24 of those entrants can claim Gold Awards, another 24 Silver Awards. 

The finalists are listed here. The winners will be revealed at tonight's ceremony and posted on mmm-online.com at 11pm. 


Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...